 |
인쇄하기
취소
|
LG on strategic alliance with Kyorin for urine incontinence drug.
LG Life Science signed an agreement of strategic allicance for the market and development of Uritos (imidafenacin), a new therapeutic drug for the incontinence of urine, with Kyorin, a Japanese pharmaceutical company.
LG Life Science has an exclusive distribution right of Uritos in Korea and cooperate with Kyorin for the business entries into the United States and European markets.
Uritos...
LG Life Science has an exclusive distribution right of Uritos in Korea and cooperate with Kyorin for the business entries into the United States and European markets.
Uritos...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.